A

Akari Therapeutics plc
D

AKTX

1.22000
USD
-0.24
(-16.44%)
Market Closed
Volume
0
EPS
-3
Div Yield
-
P/E
-0
Market Cap
14,816,432
OverviewSignalsIdeasNews
Related Instruments
    A
    ACER
    0
    (0%)
    0.000000 USD
    A
    ACRX
    0
    (0%)
    0.000000 USD
    A
    ADMA
    -1.180
    (-5.84%)
    19.030 USD
    A
    ARCT
    -2.310
    (-12.60%)
    16.020 USD
    A
    ARWR
    -2.890
    (-13.49%)
    18.540 USD
    A
    AXSM
    -4.300
    (-4.41%)
    93.150 USD
    C
    CAPR
    0.100
    (0.54%)
    18.620 USD
    C
    CPRX
    -1.070
    (-4.94%)
    20.610 USD
    I
    IMV
    0.01000
    (1.96%)
    0.51000 USD
    More
News

Title: Akari Therapeutics plc

Sector: Healthcare
Industry: Biotechnology
Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing therapies for autoimmune and inflammatory diseases involving the complement component 5 (C5) and leukotriene B4 (LTB4) pathways. The company's pipelines include HSCT-TMA and Geographic Atrophy (GA).